FDA cites firms for marketing without proper authorization, failing to maintain sterile environment
Regulatory NewsFerdous Al-Faruque
GMPPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning lettersRegulatory NewsFerdous Al-FaruqueGMPPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning letters